Oncology PracticeNine weeks of biochemotherapy effective for high-risk melanomaOctober 29, 2014Melanoma
Oncology PracticeInvestigational nivolumab beats chemo in pretreated advanced melanomaOctober 9, 2014Melanoma
Oncology PracticeVIDEO: MEK/BRAF combo puts brakes on BRAF-mutated advanced melanoma progressionOctober 3, 2014Melanoma
Oncology PracticeFocus lands on kinase fusions in Spitz tumorsSeptember 12, 2014MelanomaRare Diseases
Oncology PracticeAnal high-grade squamous intraepithelial lesions cleared in 42% of gay menSeptember 11, 2014Nonmelanoma Skin CancerMelanoma
Oncology PracticeFDA grants first approval of a PD-1 inhibitor, for advanced melanomaSeptember 4, 2014Melanoma
The Journal of Community and Supportive OncologyASCO at 50 … we’ve come a long way, we know a lot, but we’ve only just begunJuly 23, 2014Melanoma
The Journal of Community and Supportive OncologyTrametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutationsJuly 22, 2014Melanoma
